Publications by authors named "Kathy Gratton"

Claim this Profile
O
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.
Chandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo, Joanne Luider, Karen A Kopciuk, Kathy Gratton

Blood Adv· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer.
Ahmed A Mostafa, Daniel E Meyers, Chandini M Thirukkumaran, Peter J Liu, Kathy Gratton

Cancers (Basel)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma.
Keith A Lawson, Ahmed A Mostafa, Zhong Qiao Shi, Jason Spurrell, Wenqian Chen, Kathy Gratton

Clin Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.
Paola Neri, Li Ren, Kathy Gratton, Erin Stebner, Jordan Johnson

Blood· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.
Paola Neri, Li Ren, Abdel Kareem Azab, Matthew Brentnall, Kathy Gratton

Blood· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
Kelley Zwicker, Christa Chatten, Kathy Gratton, Doug Demetrick, Pau Serra

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis